View Older Stories View More Recent Stories

Feb 11, 2025 06:50AM Piper Sandler: 'Vertex (VRTX) Firing on All Cylinders'

Feb 11, 2025 06:39AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)

Feb 11, 2025 05:44AM Vertex (VRTX) PT Raised to $444 at Bernstein After Journavx and Alyftrek Launches

Feb 10, 2025 04:04PM Vertex Pharma (VRTX) Misses Q4 EPS by 4c, Revenues Beat

Feb 7, 2025 10:26AM Vertex Pharma (VRTX) call put ratio 5.1 calls to 1 put with a focus on February 14 weekly calls into quarter results

Feb 7, 2025 05:03AM Vertex Pharma (VRTX) call put ratio 2.8 calls to 1 put into quarter results

Feb 3, 2025 06:35AM Vertex (VRTX) PT Raised to $550 at H.C. Wainwright

Jan 31, 2025 08:44AM Vertex (VRTX) PT Raised to $545 at BMO Capital Following Suzetrigine's approval

Jan 31, 2025 07:34AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)

Jan 30, 2025 06:26PM Vertex Pharma (VRTX) announces FDA Approval of JOURNAVX

Jan 30, 2025 05:51PM FDA Approves Vertex's (VRTX) Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Jan 27, 2025 07:50AM Vertex (VRTX) PT Lowered to $533 at Piper Sandler on Adjusted Q424 Casgevy Revenue Estimates

Jan 24, 2025 07:33AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)

Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA

Jan 10, 2025 07:32AM Zai Lab (ZLAB) and Vertex (VRTX) Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Jan 7, 2025 09:15AM Vertex (VRTX) PT Raised to $401 at RBC Capital; 'We Would Look for a More Compelling Entry Point'

Dec 23, 2024 09:39AM Vertex (VRTX) PT Lowered to $460 at Truist Securities

Dec 23, 2024 08:27AM Vertex (VRTX) PT Raised to $430 at Scotiabank

Dec 23, 2024 02:11AM Vertex (VRTX) PT Lowered to $500 at JPMorgan

Dec 20, 2024 03:46PM Vertex Pharma (VRTX) Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Dec 20, 2024 03:37PM Vertex Pharma (VRTX) Announces U.S. FDA Approval for TRIKAFTA to Include Additional Non-F508del TRIKAFTA-Responsive Variants

Dec 20, 2024 12:41PM Vertex (VRTX) PT Lowered to $520 at BMO Capital; 'Detour Not a Breakdown'

Dec 20, 2024 06:42AM Vertex (VRTX) PT Lowered to $535 at H.C. Wainwright

Dec 20, 2024 06:19AM Bernstein on Vertex (VRTX) Post LRS miss: 'Can DPN (and the Stock) Still Work?'; PT Lowered

Dec 19, 2024 02:58PM Evercore ISI on Vertex (VRTX): 'we see upside from here in 2025'

Dec 19, 2024 02:00PM 4 themes and 4 key biotech stocks for 2025: Jefferies

Dec 19, 2024 01:40PM Oppenheimer Downgrades Vertex (VRTX) to Perform

Dec 19, 2024 11:48AM Vertex (VRTX) PT Lowered to $522 at BofA Securities

Dec 19, 2024 08:07AM Goldman Sachs Reiterates Buy Rating on Vertex (VRTX)

Dec 19, 2024 06:00AM Vertex Pharma (VRTX) Reports Results From Phase 2 Study of Suzetrigine

Dec 9, 2024 02:56AM Jefferies Upgrades Vertex (VRTX) to Buy

Dec 4, 2024 08:50AM BMO Capital: Five Key BioPharma Catalysts Through Year-End '24

Dec 2, 2024 04:00PM Here are the key catalysts for 3 US biotech stocks into year end

Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks

Nov 21, 2024 02:23PM BofA on Vertex Pharma (VRTX): 'At risk for a double top'

Nov 13, 2024 04:08PM Citi Starts Vertex (VRTX) at Buy

Nov 5, 2024 01:11PM Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)

Nov 5, 2024 07:00AM Vertex (VRTX) PT Raised to $451 at RBC Capital

Nov 4, 2024 04:03PM Vertex Pharma (VRTX) Tops Q3 EPS by 30c; raises guidance

Nov 1, 2024 11:02AM Vertex Pharma (VRTX) November 11 weekly option implied volatility into quarter results

Nov 1, 2024 05:23AM Vertex Pharma (VRTX) November 11 weekly 475 straddle priced into quarter results

Oct 25, 2024 01:00PM Vertex Pharma (VRTX) Provides Updates on Multiple Kidney Programs

Oct 22, 2024 06:52AM Canaccord Genuity Reiterates Sell Rating on Vertex (VRTX)

Oct 21, 2024 08:09AM BMO Capital Reiterates Outperform Rating on Vertex (VRTX)

Oct 21, 2024 07:39AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)

Oct 21, 2024 06:05AM Goldman Sachs Reiterates Buy Rating on Vertex (VRTX)

Oct 18, 2024 08:00AM Vertex Pharma (VRTX) to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor

Oct 10, 2024 08:24AM Raymond James Resumes Vertex (VRTX) at Market Perform

Oct 9, 2024 06:37AM Vertex (VRTX) PT Raised to $437 at RBC Capital

Oct 1, 2024 06:17AM Vertex (VRTX) PT Lowered to $518 at Wolfe Research

View More Recent Stories View Older Stories